Search Results 741-750 of 18242 for Immunode

1. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Known history of testing positive for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness. Received a live ...

2. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

3. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

   Known positive status for human immunodeficiency virus (HIV); Chronic active or acute viral hepatitis A, B, or C infection, or a hepatitis B or C carrier ...

4. A Study to Evaluate the Safety and Effectiveness of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease - Mayo Clinic

   Subject has positive test results for Human Immunodeficiency Virus (HIV) or known to be HIV-positive. Phase 1b subject cannot be a current smoker, nor have ...

5. Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors - Mayo Clinic

   Has significant immunodeficiency due to underlying illness (e.g., known HIV/AIDS) or has received systemic immunosuppressive medication including high-dose ...

6. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   Known infection with human immunodeficiency virus, or active hepatitis B or C, or other active clinically relevant liver disease. Unwillingness to receive ...

7. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or tuberculosis; Severe infections within 4 weeks prior to ...

8. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

   Known human immunodeficiency virus seropositivity. Known history / positive serology for hepatitis B (unless immune due to vaccination or resolved natural ...

9. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   Known Human Immunodeficiency Virus (HIV), active Hepatitis B Virus (HBV), and/or active Hepatitis C Virus (HCV) infection. Prior therapy with lenalidomide ...

10. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Known to be human immunodeficiency virus (HIV) seropositive; Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) ...